Compare WVE & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | AROW |
|---|---|---|
| Founded | 2012 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 673.9M | 727.7M |
| IPO Year | 2015 | 1995 |
| Metric | WVE | AROW |
|---|---|---|
| Price | $3.37 | $38.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 4 |
| Target Price | $17.05 | ★ $43.50 |
| AVG Volume (30 Days) | ★ 2.9M | 60.0K |
| Earning Date | 10-27-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 3.11% |
| EPS Growth | N/A | ★ 49.72 |
| EPS | N/A | ★ 1.48 |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | $48.79 | $26.11 |
| Revenue Next Year | N/A | $15.43 |
| P/E Ratio | ★ N/A | $26.72 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $3.04 | $28.92 |
| 52 Week High | $21.73 | $42.70 |
| Indicator | WVE | AROW |
|---|---|---|
| Relative Strength Index (RSI) | 43.99 | 54.28 |
| Support Level | $3.04 | $37.23 |
| Resistance Level | $3.97 | $40.13 |
| Average True Range (ATR) | 0.24 | 1.03 |
| MACD | 0.05 | 0.13 |
| Stochastic Oscillator | 35.14 | 52.17 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.